BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34558064)

  • 21. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
    Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
    Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions.
    Kantharia K; Owen C; Stewart D; Yau P; Ghosh S; Dersch-Mills D
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):894-902. PubMed ID: 36031543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.
    Tokuhira M; Watanabe R; Nemoto T; Sagawa M; Tomikawa T; Tamaru J; Itoyama S; Nagasawa H; Amano K; Kameda H; Takeuchi T; Mori S; Kizaki M
    Leuk Lymphoma; 2012 Apr; 53(4):616-23. PubMed ID: 21933041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
    Rizzi R; Curci P; Delia M; Rinaldi E; Chiefa A; Specchia G; Liso V
    Med Oncol; 2009; 26(1):1-9. PubMed ID: 18461290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
    Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
    J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD).
    Sekiguchi Y; Iizuka H; Takizawa H; Sugimoto K; Sakajiri S; Inano T; Fukuda Y; Shirane S; Hamano Y; Tomita S; Izumi H; Okubo M; Nakamura N; Sawada T; Sekiguchi N; Noguchi M
    Intern Med; 2020 Sep; 59(17):2165-2171. PubMed ID: 32461524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.
    Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2012; 52(3):211-8. PubMed ID: 23269082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.
    Satou A; Tabata T; Miyoshi H; Kohno K; Suzuki Y; Yamashita D; Shimada K; Kawasaki T; Sato Y; Yoshino T; Ohshima K; Takahara T; Tsuzuki T; Nakamura S
    Mod Pathol; 2019 Jul; 32(8):1135-1146. PubMed ID: 30952973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
    Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
    EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
    Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
    Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
    Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
    Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
    Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.
    Horie N; Kawano R; Kaneko T; Shimoyama T
    Aust Dent J; 2015 Sep; 60(3):408-11. PubMed ID: 25302816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
    Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
    Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.
    Saburi M; Ogata M; Yoshida N; Nashimoto Y; Moroga Y; Takano K; Kohno K; Daa T; Shirao K
    Intern Med; 2018 Apr; 57(8):1145-1149. PubMed ID: 29279493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Case of Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders With Multiple Oral Mucosal Lesions During Methotrexate Therapy.
    Hayashi I; Toida M
    Cureus; 2024 Apr; 16(4):e58995. PubMed ID: 38800284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.